Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Recurrence, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

Oncomabs

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

Fluid Biopsy for the Diagnosis of Lung Cancer

HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors

Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma

Single Nucleotide Polymorphism(SNP)Study. ICORG 08-40, V4

START

Evaluation of a New Open Source Virtual Bronchoscope Navigation System

Bronchial Mapping (GCC 1635)

SPiRiT

Lung Cancer Patients and Parent-child Interaction Experience and Process

Staging Procedures to Diagnose Malignant Pleural Mesothelioma

Circulating Tumor DNA Alterations in Non-small Cell Lung Cancer Patients Treated With Pembrolizumab

Food Reward in Cachexia Induced by Acute or Chronic Disease

Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma

LUTON

Using Infrared Spectroscopy to Analyze Volatile Organic Compounds (VOCs) in the Breath of Patients With Lung Cancer

Lung SBRT Motion Management (GCC 1619)

MOTIVATION

BEACON-LUNG

Beyond the Lung Cancer Diagnosis: Leveraging the Oncology Clinic Setting for Actively Smoking Family Members

Collection of Blood Samples in Patients With Non-small Cell Lung Cancer

Lung Cancer Case Registry and Tissue Resource

Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA

Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of Small Lung Nodules

Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy

Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy

FORESEE

Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy

Efficacy and Safety of Argon Plasma Coagulation in the Treatment of Patients With Hemoptysis Caused by Endobronchial Malignancies

Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies

NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

PADMA

Cardiac MRI Biomarker Testing (GCC 1618)

MED-VOC

IPC

A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing

Gefitinib Long-term Survivor Study

PSP

Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy

MUBULUC

Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy

LIBERTI

Concordance of Key Actionable Genomic Alterations as Assessed in Tumor Tissue and Plasma in Non Small Cell Lung Cancer

Mapping Sound Propagation Through the Human Lung for Better Diagnosis

4D Cone Beam CT Reconstruction for Radiotherapy Via Motion Vector Optimization

NanoSpectrometer Biomarker Discovery and Confirmation Study

Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients

Echocardiography for RILI Prediction